You can read the original op-ed published in STAT News here. With the new Congress mostly in place, now split between a Democratic House and a Republican Senate, a new dynamic is in place. Any legislation, including efforts to rein in drug prices, will need to have bipartisan support to move forward. Bringing pricing restraint […]
This letter was originally sent to the office of Seema Verma on October 16, 2018. NCHC expressed its support for many aspects of the rule, but also shared some concerns.